BioAge Labs (BIOA) Other Accumulated Expenses (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Other Accumulated Expenses data on file, last reported at $714000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 27.96% year-over-year to $714000.0; the trailing twelve-month figure through Mar 2026 stood at $714000.0 (up 27.96% YoY), and the FY2025 full-year result was $525000.0, up 25.9% from the prior year.
• Other Accumulated Expenses rose to $714000.0 in Q1 2026, from $525000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.7 million in Q3 2024 to a low of $417000.0 in Q4 2024.
• A 4-year average of $892500.0 and a median of $802000.0 in 2025 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses slumped 69.98% in 2024 and advanced 27.96% in 2026, its largest moves.
• Tracing BIOA's Other Accumulated Expenses over 4 years: stood at $1.4 million in 2023, then tumbled by 69.98% to $417000.0 in 2024, then gained by 25.9% to $525000.0 in 2025, then jumped by 36.0% to $714000.0 in 2026.
• Business Quant data shows BIOA's Other Accumulated Expenses at $714000.0 in Q1 2026, $525000.0 in Q4 2025, and $890000.0 in Q3 2025.